When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Etanercept - Wikipedia

   en.wikipedia.org/wiki/Etanercept

   Etanercept mimics the inhibitory effects of naturally occurring soluble TNF receptors, the difference being that etanercept, because it is a fusion protein rather than a simple TNF receptor, has a greatly extended half-life in the bloodstream, and therefore a more profound and long-lasting biologic effect than a naturally occurring soluble TNF ...

3. Biological response modifier - Wikipedia

   en.wikipedia.org/wiki/Biological_response_modifier

   Biological response modifiers (BRMs) are substances that modify immune responses.They can be endogenous (produced naturally within the body) or exogenous (as pharmaceutical drugs), and they can either enhance an immune response or suppress it.

4. Immunosuppressive drug - Wikipedia

   en.wikipedia.org/wiki/Immunosuppressive_drug

   Patients stay in the hospital as long as three weeks to give the immune system time to recover to a point where there is no longer a risk of serum sickness. Because of a high immunogenicity of polyclonal antibodies, almost all patients have an acute reaction to the treatment.

5. Immunological memory - Wikipedia

   en.wikipedia.org/wiki/Immunological_memory

   Memory cells have a long life and last up to several decades in the body. [6] [2] Immunity to chickenpox, measles, and some other diseases lasts a lifetime. Immunity to many diseases eventually wears off. The immune system's response to a few diseases, such as dengue, counterproductively worsens the next infection (antibody-dependent ...

6. Infliximab - Wikipedia

   en.wikipedia.org/wiki/Infliximab

   Infliximab, a chimeric monoclonal antibody, sold under the brand name Remicade among others, is a medication used to treat a number of autoimmune diseases.This includes Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, and Behçet's disease. [23]

7. Adalimumab - Wikipedia

   en.wikipedia.org/wiki/Adalimumab

   Adalimumab, sold under the brand name Humira and others, is a disease-modifying antirheumatic drug and monoclonal antibody used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis.